TwinBeech Capital’s Abiomed Inc ABMD Stock Holding History

TwinBeech Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,945	Closed	-$2.93M	–	1005
2022 Q3	$2.93M	Buy	11,945 +6,434	+117%	+$1.74M	0.08%	277
2022 Q2	$1.36M	Buy	+5,511	New	+$1.49M	0.06%	279
2021 Q2	–	Sell	-5,834	Closed	-$1.86M	–	712
2021 Q1	$1.86M	Buy	+5,834	New	+$1.87M	0.27%	121
2020 Q3	–	Sell	-2,263	Closed	-$547K	–	612
2020 Q2	$547K	Buy	2,263 +774	+52%	+$155K	0.12%	218
2020 Q1	$216K	Sell	1,489 -3,662	-71%	-$608K	0.09%	252
2019 Q4	$879K	Buy	+5,151	New	+$955K	0.25%	129

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TwinBeech Capital's ABMD Position: Q4 2022 in Review

TwinBeech Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,945 shares — an estimated $2.93M sold.

TwinBeech Capital first reported a position in ABMD in Q4 2019 and held it in 6 quarters. The position peaked at $2.93M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

TwinBeech Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
TwinBeech Capital sold 11,945 Abiomed Inc shares in Q4 2022, an estimated $2.93M.
TwinBeech Capital first reported a position in Abiomed Inc in Q4 2019 and held it in 6 quarters.
TwinBeech Capital's Abiomed Inc position peaked at $2.93M in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on TwinBeech Capital's 13F filing for Q4 2022, filed 14 Feb 2023.